LPL Financial LLC Acquires 6,123 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

LPL Financial LLC increased its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 21.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,198 shares of the company's stock after buying an additional 6,123 shares during the quarter. LPL Financial LLC owned about 0.07% of Prestige Consumer Healthcare worth $2,749,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. QRG Capital Management Inc. grew its holdings in shares of Prestige Consumer Healthcare by 3.3% during the 4th quarter. QRG Capital Management Inc. now owns 5,496 shares of the company's stock valued at $429,000 after purchasing an additional 176 shares during the last quarter. GAMMA Investing LLC boosted its stake in Prestige Consumer Healthcare by 18.9% during the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock valued at $108,000 after purchasing an additional 220 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Prestige Consumer Healthcare by 5.9% in the 4th quarter. PNC Financial Services Group Inc. now owns 5,276 shares of the company's stock worth $412,000 after acquiring an additional 296 shares in the last quarter. Xponance Inc. boosted its position in Prestige Consumer Healthcare by 10.1% in the fourth quarter. Xponance Inc. now owns 3,570 shares of the company's stock worth $279,000 after purchasing an additional 328 shares during the last quarter. Finally, Kestra Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $27,000. Institutional investors own 99.95% of the company's stock.

Insider Transactions at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now owns 17,157 shares of the company's stock, valued at $1,544,130. The trade was a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.60% of the company's stock.

Analyst Ratings Changes

PBH has been the subject of several analyst reports. Canaccord Genuity Group upped their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Royal Bank of Canada lifted their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a research note on Friday, March 21st. Oppenheimer raised their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a report on Thursday, February 13th. StockNews.com cut Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Tuesday, April 8th. Finally, Raymond James raised Prestige Consumer Healthcare to a "moderate buy" rating in a research note on Thursday, December 19th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $93.33.

Prestige Consumer Healthcare Stock Up 0.4 %

Shares of NYSE PBH traded up $0.31 during trading on Thursday, reaching $80.11. The company had a trading volume of 35,187 shares, compared to its average volume of 352,460. The stock has a market cap of $3.97 billion, a PE ratio of 18.76, a P/E/G ratio of 2.69 and a beta of 0.47. The business's 50-day moving average is $84.42 and its 200 day moving average is $79.97. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $90.04. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.